Education
About Us
Working with TipRanks
Follow Us
NeoGenomics (NEO)
NASDAQ:NEO
Total Valuation
NeoGenomics has a market cap or net worth of $785.41M. The enterprise value is $1.18B.
Market Cap$785.41M
Enterprise Value$1.18B
Share Statistics
NeoGenomics has 129,178,620 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding129,178,620
Owned by Insiders1.20%
Owned by Institutions0.76%
Financial Efficiency
NeoGenomics’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -5.83%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-5.83%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee300.26K
Profits Per Employee-35.78K
Employee Count2,200
Asset Turnover0.40
Inventory Turnover13.85
Valuation Ratios
The current PE Ratio of NeoGenomics is ―. NeoGenomics’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.46
Price to FCF0.00
Price to Operating Cash Flow18.34
PEG Ratio―
Income Statement
In the last 12 months, NeoGenomics had revenue of 660.57M and earned -78.73M in profits. Earnings per share was -3.10.
Revenue660.57M
Gross Profit290.10M
Operating Income-92.11M
Pretax Income-80.67M
Net Income-78.73M
EBITDA-1.51M
Earnings Per Share (EPS)-3.10
Cash Flow
In the last 12 months, operating cash flow was 5.26M and capital expenditures -2.73M, giving a free cash flow of 2.52M billion.
Operating Cash Flow5.26M
Free Cash Flow2.52M
Free Cash Flow per Share0.02
Dividends & Yields
NeoGenomics pays an annual dividend of $0.4, resulting in a dividend yield of ―
Dividend Per Share$0.4
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.32
52-Week Price Change-61.29%
50-Day Moving Average6.74
200-Day Moving Average11.05
Relative Strength Index (RSI)51.08
Average Volume (3m)2.43M
Important Dates
NeoGenomics upcoming earnings date is Nov 11, 2025, TBA (Confirmed).
Last Earnings DateJul 29, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend DateDec 17, 2020
Financial Position
NeoGenomics as a current ratio of 1.98, with Debt / Equity ratio of 68.09%
Current Ratio1.98
Quick Ratio1.89
Debt to Market Cap1.30
Net Debt to EBITDA-157.72
Interest Coverage Ratio-13.92
Taxes
In the past 12 months, NeoGenomics has paid -1.95M in taxes.
Income Tax-1.95M
Effective Tax Rate0.02
Enterprise Valuation
NeoGenomics EV to EBITDA ratio is -1.54K, with an EV/FCF ratio of -68.32.
EV to Sales3.52
EV to EBITDA-1.54K
EV to Free Cash Flow-68.32
EV to Operating Cash Flow331.15
Balance Sheet
NeoGenomics has $163.69M in cash and marketable securities with $411.76M in debt, giving a net cash position of $248.08M billion.
Cash & Marketable Securities$163.69M
Total Debt$411.76M
Net Cash$248.08M
Net Cash Per Share$1.92
Tangible Book Value Per Share$1.57
Margins
Gross margin is 43.79%, with operating margin of -13.94%, and net profit margin of -11.92%.
Gross Margin43.79%
Operating Margin-13.94%
Pretax Margin-12.21%
Net Profit Margin-11.92%
EBITDA Margin-0.23%
EBIT Margin-11.21%
Analyst Forecast
The average price target for NeoGenomics is $8.81, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.81
Price Target Upside41.19% Upside
Analyst ConsensusModerate Buy
Analyst Count12
Revenue Growth Forecast9.70%
EPS Growth Forecast-30.94%